Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine

被引:26
|
作者
Zugno, Alexandra I. [1 ]
Canever, Lara [1 ]
Heylmann, Alexandra S. [1 ]
Wessler, Patricia G. [1 ]
Steckert, Amanda [1 ]
Mastella, Gustavo A. [1 ]
de Oliveira, Mariana B. [1 ]
Damazio, Louyse S. [1 ]
Pacheco, Felipe D. [1 ]
Calixto, Octacilio P. [1 ]
Pereira, Flavio P. [1 ]
Macan, Tamires P. [3 ]
Pedro, Thayara H. [3 ]
Schuck, Patricia F. [3 ]
Quevedo, Joao [1 ,2 ]
Budni, Josiane [1 ]
机构
[1] Univ Extremo Sul Catarinense, Lab Neurociencias, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, BR-88806000 Criciuma, SC, Brazil
[2] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Sch Med, Ctr Expt Models Psychiat, Houston, TX 77030 USA
[3] Univ Extrema Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metab, Criciuma, SC, Brazil
关键词
Schizophrenia; Folic acid; Ketamine; Behavioral; Oxidative stress; LIPID-PEROXIDATION; FOLLOW-UP; FOLATE; HOMOCYSTEINE; SYMPTOMS; THERAPEUTICS; DEPRESSION; PREGNANCY; RISK; RATS;
D O I
10.1016/j.jpsychires.2016.06.013
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Recent studies have shown benefits for the supplementation of folic acid in schizophrenic patients. The aim of this study was to evaluate the effects of folic acid addition on adult rats, over a period of 7 or 14 days. It also sets out to verify any potential protective action using an animal model of schizophrenia induced by ketamine, in behavioral and biochemical parameters. This study used two protocols (acute and chronic) for the administration of ketamine at a dose of 25 mg/kg (i.p.). The folic acid was given by oral route in doses of 5, 10 and 50 mg/kg, once daily, for 7 and/or 14 days in order to compare the protective effects of folic acid. Thirty minutes after the last administration of ketamine, the locomotor and social interaction activities were evaluated, and immediately the brain structure were removed for biochemical analysis. In this study, ketamine was administered in a single dose or in doses over the course of 7 days increasing the animal's locomotion. This study showed that the administration of folic acid over 7 days was unable to prevent hyper locomotion. In contrast, folic acid (10 and 50 mg/kg) administrated over a period of 14 days, was able to partially prevent the hyper locomotion. Our data indicates that both acute and chronic administrations of ketamine increased the time to first contact between the animals, while the increased latency for social contact was completely prevented by folic acid (5, 10 and 50 mg/kg). Chronic and acute administrations of ketamine also increased lipid peroxidation and protein carbonylation in brain. Folic acid (10 and 50 mg/kg) supplements showed protective effects on the oxidative damage found in the different brain structures evaluated. All together, the results indicate that nutritional supplementation with folic acid provides promising results in an animal model of schizophrenia induced by ketamine. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:23 / 35
页数:13
相关论文
共 50 条
  • [31] Protective effect of curcumin on diazepam-induced behavioral changes and oxidative stress in rats
    Sevastre-Berghian, A.
    Fagarasan, V.
    Decea, N.
    Moldovan, R.
    Sevastre, B.
    Taulescu, M.
    Filip, A. G.
    EUROPEAN PSYCHIATRY, 2016, 33 : S286 - S286
  • [32] Evaluation of Folic Acid Protective Effect in an Animal Model of Aging Induced by D-galactose
    Budni, Josiane
    Garcez, Michelle Lima
    Garcez, Michelle Lima
    Mina, Francielle
    Sapalo Cassoma, Ricardo Chiengo
    Bellettini-Santos, Tatiani
    Schiavo, Gustavo Luis
    da Luz, Aline Pereira
    Steckert, Amanda Valnier
    Barichello, Tatiana
    Quevedo, Joao
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 76S - 76S
  • [33] Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice
    Nagai, T
    Noda, Y
    Une, T
    Furukawa, K
    Furukawa, H
    Kan, QM
    Nabeshima, T
    NEUROREPORT, 2003, 14 (02) : 269 - 272
  • [34] Synergistic effect of folic acid and galantamine against experimentally induced oxidative stress in IMR 32 cells
    Upadhyay, Shagun Dubey
    Ahmad, Yusra
    Kohli, Seema
    Sharma, R. K.
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2022, 60 (04) : 286 - 292
  • [35] The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
    Reus, Gislaine Z.
    Becker, Indianara R. T.
    Scaini, Giselli
    Petronilho, Fabricia
    Oses, Jean P.
    Kaddurah-Daouk, Rima
    Ceretta, Luciane B.
    Zugno, Alexandra I.
    Dal-Pizzol, Felipe
    Quevedo, Joao
    Barichello, Tatiana
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 81 : 55 - 63
  • [36] Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: Relevance as an animal model of mania
    Macedo, Danielle S.
    de Lucena, David F.
    Queiroz, Ana Isabelle G.
    Cordeiro, Rafaela C.
    Araujo, Maira M.
    Sousa, Francisca Clea
    Vasconcelos, Silvania M.
    Hyphantis, Thomas N.
    Quevedo, Joao
    McIntyre, Roger S.
    Carvalho, Andre F.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 43 : 230 - 237
  • [37] Effect of Serotonin-1A receptor on behavioral changes in animal model of schizophrenia-like behavior
    Bubenikova-Valesova, V.
    Votava, M.
    Palenicek, T.
    Horacek, J.
    Hoschl, C.
    EUROPEAN PSYCHIATRY, 2008, 23 : S61 - S61
  • [38] Protective Effects of Propolis on Behavioral and Stress Oxidative Changes in Cuprizone-Induced Demyelination Model
    Farhadifard, Ghazal
    Haddadi, Rasool
    Sanemar, Khashayar
    Farhadifard, Homa
    Mohammadi, Mojdeh
    CURRENT DRUG THERAPY, 2024, 19 (02) : 226 - 232
  • [39] Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia
    Alexandra I. Zugno
    Ricardo Filipe Julião
    Josiane Budni
    Ana Maria Volpato
    Daiane B. Fraga
    Felipe D. Pacheco
    Pedro F. Deroza
    Renata D. Luca
    Mariana B. de Oliveira
    Alexandra S. Heylmann
    João Quevedo
    Metabolic Brain Disease, 2013, 28 : 501 - 508
  • [40] Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine
    Valvassori, Samira S.
    Da Rosa, Richard T.
    Dal-Pont, Gustavo C.
    Varela, Roger B.
    Mastella, Gustavo A.
    Daminelli, Thiani
    Fries, Gabriel R.
    Quevedo, Joao
    Zugno, Alexandra I.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2023, 83 (08) : 691 - 702